STANDBY EQUITY
DISTRIBUTION AGREEMENT
THIS AGREEMENT dated as of the ___ day of July 2005 (the
“ Agreement ”) between CORNELL CAPITAL
PARTNERS, LP , a Delaware limited partnership (the “
Investor ”), and XSUNX, INC. , a
corporation organized and existing under the laws of the State of
Colorado (the “ Company ”).
WHEREAS , the parties desire that, upon the terms and
subject to the conditions contained herein, the Company shall issue
and sell to the Investor, from time to time as provided herein, and
the Investor shall purchase from the Company up to Ten Million
Dollars ($10,000,000) of the Company’s common stock, no
par value per share (the “ Common Stock ”);
and
WHEREAS , such investments will be made in reliance upon
the provisions of Regulation D (“ Regulation D
”) of the Securities Act of 1933, as amended, and the
regulations promulgated thereunder (the “ Securities
Act ”), and or upon such other exemption from the
registration requirements of the Securities Act as may be available
with respect to any or all of the investments to be made
hereunder.
WHEREAS , the Company has engaged Newbridge Securities
Corporation (the “ Placement Agent ”), to
act as the Company’s exclusive placement agent in connection
with the sale of the Company’s Common Stock to the Investor
hereunder pursuant to the Placement Agent Agreement dated the date
hereof by and among the Company, the Placement Agent and the
Investor (the “ Placement Agent Agreement
”).
NOW , THEREFORE , the parties
hereto agree as follows:
ARTICLE
I.
Certain
Definitions
Section 1.1. “ Advance ” shall mean the
portion of the Commitment Amount requested by the Company in the
Advance Notice.
Section 1.2. “ Advance Date ” shall mean
the date the David Gonzalez Attorney Trust Account is in receipt of
the funds from the Investor and David Gonzalez, Esq., is in
possession of free trading shares from the Company and therefore an
Advance by the Investor to the Company can be made and David
Gonzalez, Esq. can release the free trading shares to the Investor.
The Advance Date shall be the first (1 st ) Trading Day
after expiration of the applicable Pricing Period for each
Advance.
Section 1.3. “ Advance Notice ” shall mean
a written notice to the Investor setting forth the Advance amount
that the Company requests from the Investor and the Advance
Date.
Section 1.4. “ Advance Notice Date ” shall
mean each date the Company delivers to the Investor an Advance
Notice requiring the Investor to advance funds to the Company,
subject to the terms of this Agreement. No Advance Notice Date
shall be less than five (5) Trading Days after the prior Advance
Notice Date.
Section 1.5. “ Bid Price ” shall mean, on
any date, the closing bid price (as reported by Bloomberg L.P.) of
the Common Stock on the Principal Market or if the Common Stock is
not traded on a Principal Market, the highest reported bid price
for the Common Stock, as furnished by the National Association of
Securities Dealers, Inc.
Section 1.6. “ Closing ” shall mean one of
the closings of a purchase and sale of Common Stock pursuant to
Section 2.3.
Section 1.7. “ Commitment Amount ” shall
mean the aggregate amount of up to Ten Million
Dollars ($10,000,000) which the Investor has agreed to provide
to the Company in order to purchase the Company’s Common
Stock pursuant to the terms and conditions of this
Agreement.
Section 1.8. “ Commitment Period ” shall
mean the period commencing on the earlier to occur of (i) the
Effective Date, or (ii) such earlier date as the Company and the
Investor may mutually agree in writing, and expiring on the
earliest to occur of (x) the date on which the Investor shall have
made payment of Advances pursuant to this Agreement in the
aggregate amount of Ten Million Dollars ($10,000,000), (y) the
date this Agreement is terminated pursuant to Section 2.4, or (z)
the date occurring twenty-four (24) months after the Effective
Date.
Section 1.9. “ Common Stock ” shall mean
the Company’s common stock, no par value per
share.
Section 1.10. “ Condition Satisfaction Date
” shall have the meaning set forth in
Section 7.2.
Section 1.11. “ Damages ” shall mean any
loss, claim, damage, liability, costs and expenses (including,
without limitation, reasonable attorney’s fees and
disbursements and costs and expenses of expert witnesses and
investigation).
Section 1.12. “ Effective Date ” shall mean
the date on which the SEC first declares effective a Registration
Statement registering the resale of the Registrable Securities as
set forth in Section 7.2(a).
Section 1.13. “ Escrow Agreement ” shall
mean the escrow agreement among the Company, the Investor, and
David Gonzalez, Esq., dated the date hereof.
Section 1.14. “ Exchange Act ” shall mean
the Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder.
Section 1.15. “ Material Adverse Effect ”
shall mean any condition, circumstance, or situation that would
prohibit or otherwise materially interfere with the ability of the
Company to enter into and perform any of its obligations under this
Agreement or the Registration Rights Agreement in any material
respect.
Section 1.16. “ Market Price ” shall mean
the lowest closing Bid Price of the Common Stock during the Pricing
Period.
Section 1.17. “ Maximum Advance Amount ”
shall be Two Hundred Fifty Thousand Dollars ($250,000) per
Advance Notice.
Section 1.18. “ NASD ” shall mean the
National Association of Securities Dealers, Inc.
Section 1.19. “ Person ” shall mean an
individual, a corporation, a partnership, an association, a trust
or other entity or organization, including a government or
political subdivision or an agency or instrumentality
thereof.
Section 1.20. “ Placement Agent ” shall
mean Newbridge Securities Corporation, a registered
broker-dealer.
Section 1.21. “ Pricing Period ” shall mean
the five (5) consecutive Trading Days after the Advance Notice
Date.
Section 1.22. “ Principal Market ” shall
mean the Nasdaq National Market, the Nasdaq SmallCap Market, the
American Stock Exchange, the OTC Bulletin Board or the New York
Stock Exchange, whichever is at the time the principal trading
exchange or market for the Common Stock.
Section 1.23. “ Purchase Price ” shall be
set at ninety six percent (96%) of the Market Price during the
Pricing Period.
Section 1.24. “ Registrable Securities ”
shall mean the shares of Common Stock to be issued hereunder
(i) in respect of which the Registration
Statement has not been declared effective by the SEC, (ii) which
have not been sold under circumstances meeting all of the
applicable conditions of Rule 144 (or any similar provision then in
force) under the Securities Act (“ Rule 144 ”)
or (iii) which have not been otherwise transferred to a holder who
may trade such shares without restriction under the Securities Act,
and the Company has delivered a new certificate or other evidence
of ownership for such securities not bearing a restrictive
legend.
Section 1.25. “ Registration Rights Agreement
” shall mean the Registration Rights Agreement dated the date
hereof, regarding the filing of the Registration Statement for the
resale of the Registrable Securities, entered into between the
Company and the Investor.
Section 1.26. “ Registration Statement ”
shall mean a registration statement on Form S-1 or SB-2 (if use of
such form is then available to the Company pursuant to the rules of
the SEC and, if not, on such other form promulgated by the SEC for
which the Company then qualifies and which counsel for the Company
shall deem appropriate, and which form shall be available for the
resale of the Registrable Securities to be registered thereunder in
accordance with the provisions of this Agreement and the
Registration Rights Agreement, and in accordance with the intended
method of distribution of such securities), for the registration of
the resale by the Investor of the Registrable Securities under the
Securities Act.
Section 1.27. “ Regulation D ” shall have
the meaning set forth in the recitals of this Agreement.
Section 1.28. “ SEC ” shall mean the
Securities and Exchange Commission.
Section 1.29. “ Securities Act ” shall have
the meaning set forth in the recitals of this Agreement.
Section 1.30. “ SEC Documents ” shall mean
Annual Reports on Form 10-KSB, Quarterly Reports on Form 10-QSB,
Current Reports on Form 8-K and Proxy Statements of the Company as
supplemented to the date hereof, filed by the Company for a period
of at least twelve (12) months immediately preceding the date
hereof or the Advance Date, as the case may be, until such time as
the Company no longer has an obligation to maintain the
effectiveness of a Registration Statement as set forth in the
Registration Rights Agreement.
Section 1.31. “ Trading Day ” shall mean
any day during which the New York Stock Exchange shall be open for
business.
Section 1.32. “ VWAP ” shall mean the
volume weighted average price of the Company’s Common Stock
as quoted by Bloomberg, LP.
ARTICLE
II.
Advances
Section 2.1. Investments .
(a) Advances . Upon the terms and conditions set forth herein
(including, without limitation, the provisions of Article VII
hereof), on any Advance Notice Date the Company may request an
Advance by the Investor by the delivery of an Advance Notice. The
number of shares of Common Stock that the Investor shall receive
for each Advance shall be determined by dividing the amount of the
Advance by the Purchase Price. No fractional shares shall be
issued. Fractional shares shall be rounded to the next higher whole
number of shares. The aggregate maximum amount of all Advances that
the Investor shall be obligated to make under this Agreement shall
not exceed the Commitment Amount.
(a) Advance Notice . At any time during the Commitment Period, the
Company may deliver an Advance Notice to the Investor, subject to
the conditions set forth in Section 7.2; provided, however,
the amount for each Advance as designated by the Company in the
applicable Advance Notice, shall not be more than the Maximum
Advance Amount. The aggregate amount of the Advances pursuant to
this Agreement shall not exceed the Commitment Amount. The Company
acknowledges that the Investor may sell shares of the
Company’s Common Stock corresponding with a particular
Advance Notice on the day the Advance Notice is received by the
Investor. There shall be a minimum of five (5) Trading Days between
each Advance Notice Date.
(b) Date of Delivery of Advance Notice
. An Advance Notice shall be deemed
delivered on (i) the Trading Day it is received by facsimile or
otherwise by the Investor if such notice is received prior to 12:00
noon Eastern Time, or (ii) the immediately succeeding Trading Day
if it is received by facsimile or otherwise after 12:00 noon
Eastern Time on a Trading Day or at any time on a day which is not
a Trading Day. No Advance Notice may be deemed delivered on a day
that is not a Trading Day.
Section 2.3. Closings . On each Advance Date, which shall be the first
(1 st ) Trading Day after expiration of the applicable
Pricing Period for each Advance, (i) the Company shall deliver to
David Gonzalez, Esq. (the “ Escrow Agent ”)
shares of the Company’s Common Stock, representing the amount
of the Advance by the Investor pursuant to Section 2.1 herein,
registered in the name of the Investor which shall be delivered to
the Investor, or otherwise in accordance with the Escrow Agreement
and (ii) the Investor shall deliver to Escrow Agent the amount of
the Advance specified in the Advance Notice by wire transfer of
immediately available funds which shall be delivered to the
Company, or otherwise in accordance with the Escrow Agreement. In
addition, on or prior to the Advance Date, each of the Company and
the Investor shall deliver to the other through the
Investor’s counsel, all documents, instruments and writings
required to be delivered by either of them pursuant to this
Agreement in order to implement and effect the transactions
contemplated herein. Payment of funds to the Company and delivery
of the Company’s Common Stock to the Investor shall occur in
accordance with the conditions set forth above and those contained
in the Escrow Agreement; provided , however , that to
the extent the Company has not paid the fees, expenses, and
disbursements of the Investor, the Investor’s counsel, or the
Company’s counsel in accordance with Section 12.4, the amount
of such fees, expenses, and disbursements may be deducted by the
Investor (and shall be paid to the relevant party) from the amount
of the Advance with no reduction in the amount of shares of the
Company’s Common Stock to be delivered on such Advance
Date.
Section 2.4. Termination of Investment
. The obligation of the Investor to
make an Advance to the Company pursuant to this Agreement shall
terminate permanently (including with respect to an Advance Date
that has not yet occurred) in the event that (i) there shall occur
any stop order or suspension of the effectiveness of the
Registration Statement for an aggregate of fifty (50) Trading Days,
other than due to the acts of the Investor, during the Commitment
Period, or (ii) the Company shall at any time fail materially to
comply with the requirements of Article VI and such failure is not
cured within thirty (30) days after receipt of written notice from
the Investor, provided , however , that this
termination provision shall not apply to any period commencing upon
the filing of a post-effective amendment to such Registration
Statement and ending upon the date on which such post effective
amendment is declared effective by the SEC.
Section 2.5. Agreement to Advance Funds
. The Investor agrees to advance the
amount specified in the Advance Notice to the Company after the
completion of each of the following conditions and the other
conditions set forth in this Agreement:
(a) the execution and delivery by the Company, and
the Investor, of this Agreement and the Exhibits hereto;
(b) The Escrow Agent shall have received the shares
of Common Stock applicable to the Advance in accordance with
Section 2.3. Such shares shall be free of restrictive
legends.
(c) the Company’s Registration Statement with
respect to the resale of the Registrable Securities in accordance
with the terms of the Registration Rights Agreement shall have been
declared effective by the SEC;
(d) the Company shall have obtained all material
permits and qualifications required by any applicable state for the
offer and sale of the Registrable Securities, or shall have the
availability of exemptions therefrom. The sale and issuance of the
Registrable Securities shall be legally permitted by all laws and
regulations to which the Company is subject;
(e) the Company shall have filed with the
Commission in a timely manner all reports, notices and other
documents required of a “reporting company” under the
Exchange Act and applicable Commission regulations;
(f) the fees as set forth in Section 12.4 below
shall have been paid or can be withheld as provided in Section 2.3;
and
(g) the conditions set forth in Section 7.2 shall
have been satisfied.
(h) the Company shall have provided to the Investor
an acknowledgement, from the Company’s independent certified
public accountants as to its ability to provide all consents
required in order to file a registration statement in connection
with this transaction;
(i) The Company’s transfer agent shall be
DWAC eligible.
Section 2.6. Lock Up Period . On the date hereof, the Company shall obtain
from each officer and director a lock-up agreement, as defined
below, in the form annexed hereto as Schedule 2.6 agreeing to
only sell in compliance with the volume limitation of Rule
144.
Section
2.7. Hardship . In the event the Investor sells shares of the
Company’s Common Stock after receipt of an Advance Notice and
the Company fails to perform its obligations as mandated in Section
2.3, and specifically the Company fails to deliver to the Escrow
Agent on the Advance Date the shares of Common Stock corresponding
to the applicable Advance, the Company acknowledges that the
Investor shall suffer financial hardship and therefore shall be
liable for any and all losses, commissions, fees, or financial
hardship caused to the Investor.
ARTICLE
III.
Representations and
Warranties of Investor
Investor hereby represents and warrants to, and
agrees with, the Company that the following are true and as of the
date hereof and as of each Advance Date:
Section 3.1. Organization and Authorization
. The Investor is duly incorporated
or organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite power and
authority to purchase and hold the securities issuable hereunder.
The decision to invest and the execution and delivery of this
Agreement by such Investor, the performance by such Investor of its
obligations hereunder and the consummation by such Investor of the
transactions contemplated hereby have been duly authorized and
requires no other proceedings on the part of the Investor. The
undersigned has the right, power and authority to execute and
deliver this Agreement and all other instruments (including,
without limitations, the Registration Rights Agreement), on behalf
of the Investor. This Agreement has been duly executed and
delivered by the Investor and, assuming the execution and delivery
hereof and acceptance thereof by the Company, will constitute the
legal, valid and binding obligations of the Investor, enforceable
against the Investor in accordance with its terms.
Section 3.2. Evaluation of Risks . The Investor has such knowledge and
experience in financial tax and business matters as to be capable
of evaluating the merits and risks of, and bearing the economic
risks entailed by, an investment in the Company and of protecting
its interests in connection with this transaction. It recognizes
that its investment in the Company involves a high degree of
risk.
Section 3.3. No Legal Advice From the Company
. The Investor acknowledges that it
had the opportunity to review this Agreement and the transactions
contemplated by this Agreement with his or its own legal counsel
and investment and tax advisors. The Investor is relying solely on
such counsel and advisors and not on any statements or
representations of the Company or any of its representatives or
agents for legal, tax or investment advice with respect to this
investment, the transactions contemplated by this Agreement or the
securities laws of any jurisdiction.
Section 3.4. Investment Purpose . The securities are being purchased by the
Investor for its own account, and for investment purposes. The
Investor agrees not to assign or in any way transfer the
Investor’s rights to the securities or any interest therein
and acknowledges that the Company will not recognize any purported
assignment or transfer except in accordance with applicable Federal
and state securities laws. No other person has or will have a
direct or indirect beneficial interest in the securities. The
Investor agrees not to sell, hypothecate or otherwise transfer the
Investor’s securities unless the securities are registered
under Federal and applicable state securities laws or unless, in
the opinion of counsel satisfactory to the Company, an exemption
from such laws is available.
Section 3.5. Accredited Investor . The Investor is an “ Accredited
Investor ” as that term is defined in Rule 501(a)(3) of
Regulation D of the Securities Act.
Section 3.6. Information . The Investor and its advisors (and its
counsel), if any, have been furnished with all materials relating
to the business, finances and operations of the Company and
information it deemed material to making an informed investment
decision. The Investor and its advisors, if any, have been afforded
the opportunity to ask questions of the Company and its management.
Neither such inquiries nor any other due diligence investigations
conducted by such Investor or its advisors, if any, or its
representatives shall modify, amend or affect the Investor’s
right to rely on the Company’s representations and warranties
contained in this Agreement. The Investor understands that its
investment involves a high degree of risk. The Investor is in a
position regarding the Company, which, based upon employment,
family relationship or economic bargaining power, enabled and
enables such Investor to obtain information from the Company in
order to evaluate the merits and risks of this investment. The
Investor has sought such accounting, legal and tax advice, as it
has considered necessary to make an informed investment decision
with respect to this transaction.
Section 3.7. Receipt of Documents . The Investor and its counsel have received
and read in their entirety: (i) this Agreement and the Schedules
and Exhibits annexed hereto; (ii) all due diligence and other
information necessary to verify the accuracy and completeness of
such representations, warranties and covenants; (iii) the
Company’s Form 10-KSB for the year ended September 30, 2004
and Form 10-QSB for the period ended March 31, 2005; and
(iv) answers to all questions the Investor submitted to the
Company regarding an investment in the Company; and the Investor
has relied on the information contained therein and has not been
furnished any other documents, literature, memorandum or
prospectus.
Section 3.8. Registration Rights Agreement and Escrow
Agreement . The parties
have entered into the Registration Rights Agreement and the Escrow
Agreement, each dated the date hereof.
Section 3.9. No General Solicitation . Neither the Company, nor any of its
affiliates, nor any person acting on its or their behalf, has
engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D under the Securities Act) in
connection with the offer or sale of the shares of Common Stock
offered hereby.
Section 3.10. Not an Affiliate . The Investor is not an officer, director or a
person that directly, or indirectly through one or more
intermediaries, controls or is controlled by, or is under common
control with the Company or any “ Affiliate ” of
the Company (as that term is defined in Rule 405 of the Securities
Act).
Section 3.11. Trading Activities . The Investor’s trading activities with
respect to the Company’s Common Stock shall be in compliance
with all applicable federal and state securities laws, rules and
regulations and the rules and regulations of the Principal Market
on which the Company’s Common Stock is listed or traded.
Neither the Investor nor its affiliates has an open short position
in the Common Stock of the Company, the Investor agrees that it
shall not, and that it will cause its affiliates not to, engage in
any short sales of or hedging transactions with respect to the
Common Stock, provided that the Company acknowledges and
agrees that upon receipt of an Advance Notice the Investor has the
right to sell the shares to be issued to the Investor pursuant to
the Advance Notice during the applicable Pricing
Period.
ARTICLE
IV.
Representations and
Warranties of the Company
Except as stated below, on the disclosure
schedules attached hereto or in the SEC Documents (as defined
herein), the Company hereby represents and warrants to, and
covenants with, the Investor that the following are true and
correct as of the date hereof:
Section 4.1. Organization and Qualification
. The Company is duly incorporated
or organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite corporate power
to own its properties and to carry on its business as now being
conducted. Each of the Company and its subsidiaries is duly
qualified as a foreign corporation to do business and is in good
standing in every jurisdiction in which the nature of the business
conducted by it makes such qualification necessary, except to the
extent that the failure to be so qualified or be in good standing
would not have a Material Adverse Effect on the Company and its
subsidiaries taken as a whole.
Section 4.2. Authorization, Enforcement, Compliance with
Other Instruments . (i)
The Company has the requisite corporate power and authority to
enter into and perform this Agreement, the Registration Rights
Agreement, the Escrow Agreement, the Placement Agent Agreement and
any related agreements, in accordance with the terms hereof and
thereof, (ii) the execution and delivery of this Agreement, the
Registration Rights Agreement, the Escrow Agreement, the Placement
Agent Agreement and any related agreements by the Company and the
consummation by it of the transactions contemplated hereby and
thereby, have been duly authorized by the Company’s Board of
Directors and no further consent or authorization is required by
the Company, its Board of Directors or its stockholders,
(iii) this Agreement, the Registration Rights Agreement, the
Escrow Agreement, the Placement Agent Agreement and any related
agreements have been duly executed and delivered by the Company,
(iv) this Agreement, the Registration Rights Agreement, the Escrow
Agreement, the Placement Agent Agreement and assuming the execution
and delivery thereof and acceptance by the Investor and any related
agreements constitute the valid and binding obligations of the
Company enforceable against the Company in accordance with their
terms, except as such enforceability may be limited by general
principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating
to, or affecting generally, the enforcement of creditors’
rights and remedies.
Section 4.3. Capitalization . As of the date hereof, the authorized capital
stock of the Company consists of 500,000,000 shares of Common
Stock, no par value per share and 50,000,000 shares of Preferred
Stock, $0.01 par value per share (“ Preferred Stock
”), of which 121,196,239 shares of Common Stock and no shares
of Preferred Stock are issued and outstanding. All of such
outstanding shares have been validly issued and are fully paid and
nonassessable. Except as disclosed in the SEC Documents, no shares
of Common Stock are subject to preemptive rights or any other
similar rights or any liens or encumbrances suffered or permitted
by the Company. Except as disclosed in on Schedule 4.3 and the SEC
Documents and, as of the date hereof, (i) there are no
outstanding options, warrants, scrip, rights to subscribe to, calls
or commitments of any character whatsoever relating to, or
securities or rights convertible into, any shares of capital stock
of the Company or any of its subsidiaries, or contracts,
commitments, understandings or arrangements by which the Company or
any of its subsidiaries is or may become bound to issue additional
shares of capital stock of the Company or any of its subsidiaries
or options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities
or rights convertible into, any shares of capital stock of the
Company or any of its subsidiaries, (ii) there are no outstanding
debt securities ( iii) there are no
outstanding registration statements other than on Form S-8 and (iv)
there are no agreements or arrangements under which the Company or
any of its subsidiaries is obligated to register the sale of any of
their securities under the Securities Act (except pursuant to the
Registration Rights Agreement). There are no securities or
instruments containing anti-dilution or similar provisions that
will be triggered by this Agreement or any related agreement or the
consummation of the transactions described herein or therein. The
Company has furnished to the Investor true and correct copies of
the Company’s Certificate of Incorporation, as amended and as
in effect on the date hereof (the “ Certificate of
Incorporation ”), and the Company’s By-laws, as in
effect on the date hereof (the “ By-laws ”), and
the terms of all securities convertible into or exercisable for
Common Stock and the material rights of the holders thereof in
respect thereto.
Section 4.4. No Conflict . The execution, delivery and performance of
this Agreement by the Company and the consummation by the Company
of the transactions contemplated hereby will not (i) result in a
violation of the Certificate of Incorporation, any certificate of
designations of any outstanding series of preferred stock of the
Company or By-laws or (ii) conflict with or constitute a default
(or an event which with notice or lapse of time or both would
become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any
agreement, indenture or instrument to which the Company or any of
its subsidiaries is a party, or result in a violation of any law,
rule, regulation, order, judgment or decree (including federal and
state securities laws and regulations and the rules and regulations
of the Principal Market on which the Common Stock is quoted)
applicable to the Company or any of its subsidiaries or by which
any material property or asset of the Company or any of its
subsidiaries is bound or affected and which would cause a Material
Adverse Effect. Except as disclosed in the SEC Documents, neither
the Company nor its subsidiaries is in violation of any term of or
in default under its Articles of Incorporation or By-laws or their
organizational charter or by-laws, respectively, or any material
contract, agreement, mortgage, indebtedness, indenture, instrument,
judgment, decree or order or any statute, rule or regulation
applicable to the Company or its subsidiaries. The business of the
Company and its subsidiaries is not being conducted in violation of
any material law, ordinance, regulation of any governmental entity.
Except as specifically contemplated by this Agreement and as
required under the Securities Act and any applicable state
securities laws, the Company is not required to obtain any consent,
authorization or order of, or make any filing or registration with,
any court or governmental agency in order for it to execute,
deliver or perform any of its obligations under or contemplated by
this Agreement or the Registration Rights Agreement in accordance
with the terms hereof or thereof. All consents, authorizations,
orders, filings and registrations which the Company is required to
obtain pursuant to the preceding sentence have been obtained or
effected on or prior to the date hereof. The Company and its
subsidiaries are unaware of any fact or circumstance which might
give rise to any of the foregoing.
Section 4.5. SEC Documents; Financial Statements
. Since January 1, 2003, the Company
has filed all reports, schedules, forms, statements and other
documents required to be filed by it with the SEC under of the
Exchange Act. The Company has delivered to the Investor or its
representatives, or made available through the
SEC’s